These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 14594192)

  • 21. Dexamethasone-suppressible hyperaldosteronism: studies on overproduction of 18-hydroxycortisol in three affected family members.
    Davis JR; Burt D; Corrie JE; Edwards CR; Sheppard MC
    Clin Endocrinol (Oxf); 1988 Sep; 29(3):297-308. PubMed ID: 3251669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver function, plasma dexamethasone, and DST results in detoxified alcoholics.
    Carson SW; Halbreich U; Yeh CM; Galanter M
    Psychiatry Res; 1989 Nov; 30(2):217-21. PubMed ID: 2616688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum ubiquitin levels in patients with alcoholic liver disease.
    Takagi M; Yamauchi M; Toda G; Takada K; Hirakawa T; Ohkawa K
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):76S-80S. PubMed ID: 10235284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ratio of urinary 6beta-hydroxycortisol to 17-hydroxycorticosteroids in patients with liver disease.
    Eade OE; Maddison A; Leonard PJ; Wright R
    Digestion; 1977; 16(1-2):169-74. PubMed ID: 615730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.
    Kawai S; Ichikawa Y; Homma M
    J Clin Endocrinol Metab; 1985 May; 60(5):848-54. PubMed ID: 3980669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity of alcoholic liver disease and markers of thyroid and steroid status.
    Burra P; Franklyn JA; Ramsden DB; Elias E; Sheppard MC
    Postgrad Med J; 1992 Oct; 68(804):804-10. PubMed ID: 1461852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassay of 6beta-hydroxycortisol in human plasma and urine.
    Kishida S; Fukushima DK
    Steroids; 1977 Dec; 30(6):741-9. PubMed ID: 611639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cortisone concentration as measured by radioimmunoassay.
    Srivastava LS; Werk EE; Thrasher K; Sholiton LJ; Kozera R; Nolten W; Knowles HC
    J Clin Endocrinol Metab; 1973 May; 36(5):937-43. PubMed ID: 4349049
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversibility of increased formation of catecholamines in patients with alcoholic liver disease.
    Parlesak A; Reisenauer C; Biermann J; Ratge D; Bode JC; Bode C
    Scand J Gastroenterol; 2004 Jan; 39(1):60-6. PubMed ID: 14992563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioimmunoassay for plasma betamethasone and its application for clinical study (author's transl)].
    Kano T; Mizuchi A; Miyachi Y
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):654-65. PubMed ID: 80333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunological determination of plasma cortisol.
    Vecsei P; Penke B; Katzy R; Baek L
    Experientia; 1972 Sep; 28(9):1104-5. PubMed ID: 4353036
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma cortisol differences between normal and glaucomatous patients: before and after dexamethasone suppresion.
    Schwartz B; Levene RZ
    Arch Ophthalmol; 1972 Apr; 87(4):369-77. PubMed ID: 5018239
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute effects of ethanol on plasma cortisol concentrations.
    Elias AN; Gwinup G
    Clin Endocrinol (Oxf); 1984 Jun; 20(6):731-2. PubMed ID: 6088127
    [No Abstract]   [Full Text] [Related]  

  • 34. [Radioimmunoassay for dexamethasone and its plasma levels after oral administration in patients with liver disease].
    Murakami M; Miyachi Y; Nanno M; Yoshimi T
    Nihon Naibunpi Gakkai Zasshi; 1990 Aug; 66(8):760-9. PubMed ID: 2209923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced urinary 6beta-hydroxycortisol to cortisol ratios in patients with liver cirrhosis.
    Shibuya M; Echizen H; Kubo S; Tamura N; Suzuki K; Ushiama H; Ohnishi A
    Hepatol Res; 2003 May; 26(1):28-33. PubMed ID: 12787801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vivo conversion of cortisol-4-C14 to 6beta-hydroxycortisol-4-C14 by the human cirrhotic liver.
    COHN GL; UPTON V; BONDY PK
    J Clin Endocrinol Metab; 1961 Oct; 21():1328-30. PubMed ID: 13880351
    [No Abstract]   [Full Text] [Related]  

  • 37. Cortisol metabolism in lymphocytes from cancer-bearing patients.
    Klein A; Kaufmann H; Mannheimer S; Joshua H
    Metabolism; 1978 Jun; 27(6):731-6. PubMed ID: 651657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortisol and 11 beta-hydroxysteroid dehydrogenase type 2 as potential determinants of renal citrate excretion in healthy children.
    Hua Y; Esche J; Hartmann MF; Maser-Gluth C; Wudy SA; Remer T
    Endocrine; 2020 Feb; 67(2):442-448. PubMed ID: 31813102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.
    Eldesoky ES; Kamel SI; Farghaly AM; Bakheet MY; Hedaya MA; Siest JP
    Biomark Insights; 2007 Feb; 1():157-64. PubMed ID: 19690646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma 6beta-hydroxycortisol measurements for assessing altered hepatic drug metabolizing enzyme activity.
    Szücs N; Varga I; Patócs A; Tóth M; Jakab C; Gláz E; Rácz K
    Acta Physiol Hung; 2003; 90(3):217-23. PubMed ID: 14594192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.